IDEAS home Printed from https://ideas.repec.org/a/spr/pharme/v38y2020i10d10.1007_s40273-020-00944-0.html
   My bibliography  Save this article

Incorporating Pharmacometrics into Pharmacoeconomic Models: Applications from Drug Development

Author

Listed:
  • Meenakshi Srinivasan

    (University of North Texas System College of Pharmacy)

  • Annesha White

    (University of North Texas System College of Pharmacy)

  • Ayyappa Chaturvedula

    (University of North Texas System College of Pharmacy)

  • Valvanera Vozmediano

    (University of Florida)

  • Stephan Schmidt

    (University of Florida)

  • Leo Plouffe

    (Bayer HealthCare)

  • La’Marcus T. Wingate

    (Howard University)

Abstract

Pharmacometrics is the science of quantifying the relationship between the pharmacokinetics and pharmacodynamics of drugs in combination with disease models and trial information to aid in drug development and dosing optimization for clinical practice. Considering the variability in the dose–concentration–effect relationship of drugs, an opportunity exists in linking pharmacokinetic and pharmacodynamic model-based estimates with pharmacoeconomic models. This link may provide early estimates of the cost effectiveness of drug therapies, thus informing late-stage drug development, pricing, and reimbursement decisions. Published case studies have demonstrated how integrated pharmacokinetic–pharmacodynamic–pharmacoeconomic models can complement traditional pharmacoeconomic analyses by identifying the impact of specific patient sub-groups, dose, dosing schedules, and adherence on the cost effectiveness of drugs, thus providing a mechanistic basis to predict the economic value of new drugs. Greater collaboration between the pharmacoeconomics and pharmacometrics community can enable methodological improvements in pharmacokinetic–pharmacodynamic–pharmacoeconomic models to support drug development.

Suggested Citation

  • Meenakshi Srinivasan & Annesha White & Ayyappa Chaturvedula & Valvanera Vozmediano & Stephan Schmidt & Leo Plouffe & La’Marcus T. Wingate, 2020. "Incorporating Pharmacometrics into Pharmacoeconomic Models: Applications from Drug Development," PharmacoEconomics, Springer, vol. 38(10), pages 1031-1042, October.
    • Handle: RePEc:spr:pharme:v:38:y:2020:i:10:d:10.1007_s40273-020-00944-0
    DOI: 10.1007/s40273-020-00944-0
    as

    Download full text from publisher

    File URL: http://link.springer.com/10.1007/s40273-020-00944-0
    File Function: Abstract
    Download Restriction: Access to the full text of the articles in this series is restricted.
    File URL: https://libkey.io/10.1007/s40273-020-00944-0?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    As the access to this document is restricted, you may want to search for a different version of it.

    Citations

    Blog mentions

    As found by EconAcademics.org, the blog aggregator for Economics research:
    1. Chris Sampson’s journal round-up for 12th October 2020
      by Chris Sampson in The Academic Health Economists' Blog on 2020-10-12 11:00:03

    Citations

    Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
    as


    Cited by:

    1. Marjanne A. Piena & Natalie Houwing & Carla W. Kraan & Xiaofeng Wang & Heidi Waters & Ruth A. Duffy & Suresh Mallikaarjun & Craig Bennison, 2022. "An Integrated Pharmacokinetic–Pharmacodynamic–Pharmacoeconomic Modeling Method to Evaluate Treatments for Adults with Schizophrenia," PharmacoEconomics, Springer, vol. 40(1), pages 121-131, January.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:spr:pharme:v:38:y:2020:i:10:d:10.1007_s40273-020-00944-0. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.springer.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.